Showing results (251-260 of 351) with videos related to
Sort By:
Pageof 36
AIDS (London, England)|February 9, 2016
Is nelfinavir exposure associated with cancer incidence in HIV-positive individuals?David C Boettiger, Caroline A Sabin, Andrew Grulich, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|July 24, 2018
Engagement in HIV Care Among Young Female Sex Workers in ZimbabweSue Napierala, Sungai Tafadzwa Chabata, Elizabeth Fearon, et al.Journal of the International AIDS Society|June 21, 2020
Statins for atherosclerotic cardiovascular disease prevention in people living with HIV in Thailand: a cost-effectiveness analysisDavid C Boettiger, Anthony T Newall, Pairoj Chattranukulchai, et al.Diabetes Care|February 13, 2008
Incidence and risk factors for new-onset diabetes in HIV-infected patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) studyStephane De Wit, Caroline A Sabin, Rainer Weber, et al.Lancet (London, England)|November 1, 2025
Who pays and what pays off in sexual and reproductive health? A review of the cost and cost-effectiveness of interventions and implications for future funding and marketsGesine Meyer-Rath, Lise Jamieson, Edinah Mudimu, et al.European Journal of Preventive Cardiology|April 18, 2015
An updated prediction model of the global risk of cardiovascular disease in HIV-positive persons: The Data-collection on Adverse Effects of Anti-HIV Drugs (D:A:D) studyNina Friis-Møller, Lene Ryom, Colette Smith, et al.AIDS (London, England)|January 12, 2016
Use of antiretroviral therapy and risk of end-stage liver disease and hepatocellular carcinoma in HIV-positive personsLene Ryom, Jens Dilling Lundgren, Stéphane De Wit, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|April 10, 2019
How Can Programs Better Support Female Sex Workers to Avoid HIV Infection in Zimbabwe? A Prevention Cascade AnalysisElizabeth Fearon, Andrew Phillips, Sibongile Mtetwa, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 24, 2012
Antiretroviral drug-related liver mortality among HIV-positive persons in the absence of hepatitis B or C virus coinfection: the data collection on adverse events of anti-HIV drugs studyHelen Kovari, Caroline A Sabin, Bruno Ledergerber, et al.Antiviral Therapy|April 27, 2016
Longitudinal analysis of the associations between antiretroviral therapy, viraemia and immunosuppression with lipid levels: the D:A:D studyDavid A Kamara, Colette Smith, Lene Ryom, et al.Pageof 36